BBHC
RMD icon

Brown Brothers Harriman & Co’s ResMed RMD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Buy
2,063
+271
+15% +$56.2K ﹤0.01% 746
2026
Q1 		$402K Buy
1,792
+870
+94% +$217K ﹤0.01% 669
2025
Q4 		$222K Buy
922
+191
+26% +$48.8K ﹤0.01% 732
2025
Q3 		$200K Buy
731
+263
+56% +$71.8K ﹤0.01% 690
2025
Q2 		$121K Buy
468
+148
+46% +$35.3K ﹤0.01% 746
2025
Q1 		$71.6K Buy
320
+6
+2% +$1.4K ﹤0.01% 767
2024
Q4 		$71.8K Buy
314
+37
+13% +$8.91K ﹤0.01% 803
2024
Q3 		$67.6K Buy
277
+19
+7% +$4.25K ﹤0.01% 756
2024
Q2 		$49.4K Hold
258
– – ﹤0.01% 768
2024
Q1 		$51.1K Hold
258
– – ﹤0.01% 766
2023
Q4 		$44.4K Sell
258
-10
-4% -$1.54K ﹤0.01% 742
2023
Q3 		$39.6K Sell
268
-535
-67% -$96.7K ﹤0.01% 741
2023
Q2 		$175K Sell
803
-5
-0.6% -$1.11K ﹤0.01% 499
2023
Q1 		$177K Buy
808
+501
+163% +$109K ﹤0.01% 505
2022
Q4 		$63.9K Buy
307
+255
+490% +$56K ﹤0.01% 676
2022
Q3 		$11K Sell
52
-12
-19% -$2.73K ﹤0.01% 1134
2022
Q2 		$13K Buy
64
+35
+121% +$7.45K ﹤0.01% 970
2022
Q1 		$7K Sell
29
-11
-28% -$2.66K ﹤0.01% 1088
2021
Q4 		$10K Sell
40
-114
-74% -$29.6K ﹤0.01% 919
2021
Q3 		$41K Buy
154
+125
+431% +$34.2K ﹤0.01% 714
2021
Q2 		$7K Buy
29
+6
+26% +$1.26K ﹤0.01% 952
2021
Q1 		$4K Buy
23
+19
+475% +$3.81K ﹤0.01% 988
2020
Q4 		$1K Sell
4
-20
-83% -$3.99K ﹤0.01% 1067
2020
Q3 		$4K Hold
24
– – ﹤0.01% 852
2020
Q2 		$5K Buy
24
+4
+20% +$654 ﹤0.01% 823
2020
Q1 		$3K Sell
20
-600
-97% -$95.6K ﹤0.01% 885
2019
Q4 		$96K Buy
620
+314
+103% +$45.3K ﹤0.01% 571
2019
Q3 		$41K Buy
+306
New +$40.1K ﹤0.01% 676
2019
Q1 		– Sell
-41
Closed -$5K – 1090
2018
Q4 		$5K Buy
+41
New +$4.39K ﹤0.01% 785

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brown Brothers Harriman & Co's RMD Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its ResMed (RMD) stake by 15% in Q2 2026, buying an estimated $56.2K and bringing the position to 2,063 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Brown Brothers Harriman & Co first reported a position in RMD in Q4 2018 and has held it in 29 quarters since. The position peaked at $402K in Q1 2026. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Brown Brothers Harriman & Co held 2,063 shares of ResMed worth $402K as of Q2 2026.
  • Brown Brothers Harriman & Co bought 271 ResMed shares in Q2 2026, an estimated $56.2K.
  • ResMed made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #746 holding.
  • Brown Brothers Harriman & Co first reported a position in ResMed in Q4 2018 and has held it in 29 quarters since.
  • Brown Brothers Harriman & Co's ResMed position peaked at $402K in Q1 2026.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.